ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 14 analysts with an average price target of $13.55. This is a potential upside of $11.38 (524.42%) from yesterday's end of day stock price of $2.17.

Allogene Therapeutics's activity chart (see below) currently has 102 price targets and 119 ratings on display. The stock rating distribution of ALLO is 87.23% BUY and 12.77% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.89% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $13, Lowest price target is $4.6, average price target is $13.55.

Most recent stock forecast was given by BIREN AMIN from JEFFERIES on 14-Nov-2024. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 41 are a BUY (87.23%), 6 are a HOLD (12.77%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$6.83 (314.75%)

$11

3 months 8 days ago
(14-Nov-2024)

2/8 (25%)

$6.54 (265.85%)

3

Buy

$10

$7.83 (360.83%)

$11

3 months 14 days ago
(08-Nov-2024)

0/2 (0%)

$6.92 (224.68%)

Buy

$9

$6.83 (314.75%)

$9

3 months 14 days ago
(08-Nov-2024)

0/9 (0%)

$5.92 (192.21%)

Buy

6 months 13 days ago
(09-Aug-2024)

2/9 (22.22%)

$12.2 (210.34%)

94

Buy

6 months 14 days ago
(08-Aug-2024)

1/2 (50%)

$37.38 (212.15%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 23.89

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 1 price targets and 6 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?